Vident Advisory, LLC Laboratory Corp Of America Holdings Transaction History

Vident Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $12,331 - $13,721	59 Added 5.35%	1,161 $254 Million
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $9.38 Million - $10.8 Million	-47,426 Reduced 97.73%	1,102 $250 Million
Q3 2023 Feb 21, 2024	BUY	$201.05 - $221.7 $9.53 Million - $10.5 Million	47,426 Added 4303.63%	48,528 $9.76 Billion
Q3 2023 Nov 14, 2023	BUY	$201.05 - $221.7 $9.76 Million - $10.8 Million	48,528 New	48,528 $9.76 Billion

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.